Approval · Notice of Compliance 5976 · 1994
GENTAMICIN: Notice of Compliance 5976
Issued March 16, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5976
- Date
- March 16, 1994
- Company
- Baxter CorporationMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in packaging
- Therapeutic class
- Antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GENTAMICIN | 02082144 | Cancelled Post Market |
Medicinal ingredients
- GENTAMICIN SULFATE 1.2 MG per ML